Results 271 to 280 of about 250,918 (350)

Recent Progress and Potential of G4 Ligands in Cancer Immunotherapy. [PDF]

open access: yesMolecules
Lin J   +7 more
europepmc   +1 more source

Recent Advances in Cancer Cell Membrane‐Based Nanoparticles and Cancer Cell‐Derived Small Extracellular Vesicles as Drug Delivery Platforms

open access: yesAdvanced NanoBiomed Research, EarlyView.
Cancer cell membrane‐based nanoparticles (CCM‐NPs) and cancer cell‐derived small extracellular vesicles (CsEVs) are emerging as promising drug delivery systems for targeted cancer treatment. Advances in nanotechnology have paved the way for innovative drug delivery systems that enhance the effectiveness of cancer treatment.
Wei Zhang   +4 more
wiley   +1 more source

H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.

open access: hybrid, 1988
Ivan E. Collier   +9 more
openalex   +1 more source

Aging and tumors: a dynamic interaction. [PDF]

open access: yesDiscov Oncol
Zhang Y   +6 more
europepmc   +1 more source

Wild-type p53 can inhibit oncogene-mediated focus formation.

open access: green, 1989
Daniel Eliyahu   +4 more
openalex   +1 more source

A Single‐Molecule Liposome Assay for Membrane Permeabilisation

open access: yesAngewandte Chemie International Edition, Accepted Article.
Cell membrane disruption is associated with numerous diseases and underlies the activity of various antimicrobial agents. The rapid screening of compounds capable of disrupting or permeabilising biological membranes is essential to the search for new therapeutic drugs.
Krzysztof Marek Bąk   +9 more
wiley   +1 more source

Transcriptome-scale analysis of functional alternative back-splicing events in colorectal cancer. [PDF]

open access: yesJ Transl Med
Ning Q   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy